Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Allen

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|February 13, 1999
Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAPW Zhao, J S Schorey, R Groger, et al.
Journal of Oral Surgery (American Dental Association : 1965)|April 11, 1976
Clinicopathological conference. Case 14, part 2. Arterial (arteriovenous) angiomaP M Allen, J D Black, B B Toth, et al.
Journal of Oral Surgery (American Dental Association : 1965)|March 11, 1976
Clinico-pathological conference. Case 14, part 1P M Allen, J D Black, B B Toth, et al.
International Immunology|January 1, 1989
Enhanced immunogenicity of a T cell immunogenic peptide by modifications of its N and C terminiP M Allen, G R Matsueda, S Adams, et al.
Immunity|August 1, 1996
Altered T cell receptor ligands trigger a subset of early T cell signalsJ D Rabinowitz, C Beeson, C Wülfing, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligandG J Kersh, D L Donermeyer, K E Frederick, et al.
Nature|June 1, 1987
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitopeP M Allen, G R Matsueda, R J Evans, et al.
Science (New York, N.Y.)|July 10, 1999
The immunological synapse: a molecular machine controlling T cell activationA Grakoui, S K Bromley, C Sumen, et al.
Protein Engineering, Design & Selection : PEDS|March 22, 2006
Development of a novel strategy for engineering high-affinity proteins by yeast displayS A Richman, S J Healan, K S Weber, et al.
Immunity|September 12, 2000
Eradication of established tumors by CD8+ T cell adoptive immunotherapyH L Hanson, D L Donermeyer, H Ikeda, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|February 13, 1999
Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAPW Zhao, J S Schorey, R Groger, et al.
Journal of Oral Surgery (American Dental Association : 1965)|April 11, 1976
Clinicopathological conference. Case 14, part 2. Arterial (arteriovenous) angiomaP M Allen, J D Black, B B Toth, et al.
Journal of Oral Surgery (American Dental Association : 1965)|March 11, 1976
Clinico-pathological conference. Case 14, part 1P M Allen, J D Black, B B Toth, et al.
International Immunology|January 1, 1989
Enhanced immunogenicity of a T cell immunogenic peptide by modifications of its N and C terminiP M Allen, G R Matsueda, S Adams, et al.
Immunity|August 1, 1996
Altered T cell receptor ligands trigger a subset of early T cell signalsJ D Rabinowitz, C Beeson, C Wülfing, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligandG J Kersh, D L Donermeyer, K E Frederick, et al.
Nature|June 1, 1987
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitopeP M Allen, G R Matsueda, R J Evans, et al.
Science (New York, N.Y.)|July 10, 1999
The immunological synapse: a molecular machine controlling T cell activationA Grakoui, S K Bromley, C Sumen, et al.
Protein Engineering, Design & Selection : PEDS|March 22, 2006
Development of a novel strategy for engineering high-affinity proteins by yeast displayS A Richman, S J Healan, K S Weber, et al.
Immunity|September 12, 2000
Eradication of established tumors by CD8+ T cell adoptive immunotherapyH L Hanson, D L Donermeyer, H Ikeda, et al.
Pageof 15